Login
Velsera blog - insights on the future of precision medicine
BLOG

Discussing the future of precision medicine.

Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2

Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2

FDA’s ruling on enforcement of in vitro diagnostic (IVD) medical device requirements for laboratory-developed tests (LDTs) was published in May of 2024. Barring delays from legal or legislative action, enforcement of Stage 1 will begin in 9 months. W...
go to article
Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You

Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You

FDA's New LDT Rule: An Overview
go to article
Navigating your molecular lab’s test selection and development over the next two years

Navigating your molecular lab’s test selection and development over the next two years

With the FDA’s publication of the final rule on laboratory developed tests (LDTs) on May 6, 2024, cl...
go to article
Four Years, Five Stages: the FDA's Final Rule on LDTs

Four Years, Five Stages: the FDA's Final Rule on LDTs

After over a decade-long saga, the Food and Drug Administration (FDA) published its final rule on La...
go to article
Velsera_blog

Meeting the NIH Data Management and Sharing (DMS) policy requirements

The Velsera suite of NIH-funded platforms including Cancer Genomics Cloud (CGC), BioData Catalyst Po...
go to article
Velsera_blog

Highly Customizable Multi-sample Single Cell RNA-Seq Pipeline on CGC

The reasons and rationale behind single-cell RNA-Seq “To study human biology, we must know our cells...
go to article
load more